AMRING PHARMS FDA Approval ANDA 065219

ANDA 065219

AMRING PHARMS

FDA Drug Application

Application #065219

Application Sponsors

ANDA 065219AMRING PHARMS

Marketing Status

Prescription001

Application Products

001SUSPENSION/DROPS;OTIC1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML0NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

FDA Submissions

ORIG1AP2006-05-01

TE Codes

001PrescriptionAT

CDER Filings

AMRING PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65219
            [companyName] => AMRING PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE","activeIngredients":"HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","strength":"1%;EQ 3.5MG BASE\/ML;10,000 UNITS\/ML","dosageForm":"SUSPENSION\/DROPS;OTIC","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE","submission":"HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","actionType":"1%;EQ 3.5MG BASE\/ML;10,000 UNITS\/ML","submissionClassification":"SUSPENSION\/DROPS;OTIC","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.